Literature DB >> 10430086

Differential expression of antiapoptotic gene BAG-1 in human breast normal and cancer cell lines and tissues.

X Yang1, Y Hao, Z Ding, A Pater, S C Tang.   

Abstract

BAG-1 is an antiapoptotic protein that binds to and enhances the antiapoptotic activity of Bcl-2. It binds several growth factor and hormone receptors and modulates their function. BAG-1 was also shown recently to be expressed as four protein isoforms, p50, p46, p33, and p29, through alternative translation initiation. Although many apoptosis-associated genes have been linked to oncogenesis of human breast cancer, the role of BAG-1 has not been fully elucidated. In this study, we examined the expression of BAG-1 RNA or protein isoforms and its interacting antiapoptotic proteins, Bcl-2 and BcI-X(L), in breast normal and tumor cell lines and tissues by Northern or Western blot analysis. We provide convincing evidence that both BAG-1 RNA and protein are overexpressed in human breast cancer cell lines. More importantly, we found that the expression of two isoforms of BAG-1, p46 and p33, was also much higher in breast primary tumors. The expression of Bcl-2 and Bcl-X(L) correlated with that of BAG-1 in breast normal and carcinoma cell lines but not tissues. Our study suggests that BAG-1 isoforms may serve as a molecular marker, independent of Bcl-2 and Bcl-X(L), for human breast cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430086

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  9 in total

1.  BAG-1L Protects SH-SY5Y Neuroblastoma Cells Against Hypoxia/Re-oxygenation Through Up-Regulating HSP70 and Activating PI3K/AKT Signaling Pathway.

Authors:  Yun Wang; Chao Jia; Qing-Shu Li; Chun-Yu Xie; Nan Zhang; Yan Qu
Journal:  Neurochem Res       Date:  2017-05-18       Impact factor: 3.996

2.  Spontaneously immortalised bovine mammary epithelial cells exhibit a distinct gene expression pattern from the breast cancer cells.

Authors:  Chenfu Zhao; Lu Meng; Hongyu Hu; Xudong Wang; Fangyu Shi; Yajuan Wang; Qianqian Li; Aixing Lin
Journal:  BMC Cell Biol       Date:  2010-10-22       Impact factor: 4.241

3.  MiR-138 Suppresses Cell Proliferation by Targeting Bag-1 in Gallbladder Carcinoma.

Authors:  Fei Ma; Mingdi Zhang; Wei Gong; Mingzhe Weng; Zhiwei Quan
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

4.  Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis.

Authors:  Anja Bruchmann; Corinna Roller; Tamara Vanessa Walther; Georg Schäfer; Sara Lehmusvaara; Tapio Visakorpi; Helmut Klocker; Andrew C B Cato; Danilo Maddalo
Journal:  BMC Cancer       Date:  2013-03-01       Impact factor: 4.430

5.  Cloning and functional analysis of FLJ20420: a novel transcription factor for the BAG-1 promoter.

Authors:  Hongyu Liu; Ying Li; Yongwen Li; Baoxin Liu; Heng Wu; Jing Wang; Yuli Wang; Min Wang; Shou-Ching Tang; Qinghua Zhou; Jun Chen
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

6.  Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer.

Authors:  Yasmine Nadler; Robert L Camp; Jennifer M Giltnane; Christopher Moeder; David L Rimm; Harriet M Kluger; Yuval Kluger
Journal:  Breast Cancer Res       Date:  2008-04-23       Impact factor: 6.466

7.  The Bag-1 inhibitor, Thio-2, reverses an atypical 3D morphology driven by Bag-1L overexpression in a MCF-10A model of ductal carcinoma in situ.

Authors:  E S Papadakis; C R Barker; H Syed; T Reeves; S Schwaiger; H Stuppner; J Troppmair; J P Blaydes; R I Cutress
Journal:  Oncogenesis       Date:  2016-04-04       Impact factor: 7.485

8.  A combination of trastuzumab and BAG-1 inhibition synergistically targets HER2 positive breast cancer cells.

Authors:  Emmanouil Papadakis; Natalia Robson; Alison Yeomans; Sarah Bailey; Stephanie Laversin; Stephen Beers; A Emre Sayan; Margaret Ashton-Key; Stefan Schwaiger; Hermann Stuppner; Jakob Troppmair; Graham Packham; Ramsey Cutress
Journal:  Oncotarget       Date:  2016-04-05

Review 9.  BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses.

Authors:  E S Papadakis; T Reeves; N H Robson; T Maishman; G Packham; R I Cutress
Journal:  Br J Cancer       Date:  2017-05-16       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.